Problem 19 - Biology

Question

A scientist notices that a cancer cell line fails to die when he adds an inducer of apoptosis to his culture of cells. Which hypothesis could explain why the cells fail to die? a. The cells have a mutation that prevents the initiation of apoptosis signaling. b. The cells have lost expression of the receptor for the apoptosis-inducing ligand. c. The cells overexpress a growth factor pathway that inhibits apoptosis. d. All of the above.

Step-by-Step Solution

Answer

d. All of the above.

Step 1: Understand the problem

A scientist added an inducer of apoptosis to a cancer cell culture, but the cells did not die. The task is to propose a hypothesis explaining this observation.

Step 2: Evaluate hypothesis a

Hypothesis a suggests that the cells have a mutation preventing the initiation of apoptosis signaling. If apoptosis signaling cannot start, cells would not die in response to the inducer.

Step 3: Evaluate hypothesis b

Hypothesis b suggests that the cells have lost expression of the receptor for the apoptosis-inducing ligand. Without the receptor, the cells cannot detect the apoptosis inducer and would fail to undergo apoptosis.

Step 4: Evaluate hypothesis c

Hypothesis c suggests that the cells over-express a growth factor pathway that inhibits apoptosis. An active growth factor pathway could prevent apoptosis despite the presence of an inducer.

Step 5: Evaluate hypothesis d

Hypothesis d considers that all of the above explanations could be simultaneously true, meaning the cells might have multiple mechanisms preventing apoptosis.

Step 6: Choose the most comprehensive hypothesis

Hypothesis d, 'All of the above,' is the most comprehensive as it covers multiple mechanisms that could all contribute to the failure of apoptosis in the cancer cells.

Key Concepts

Apoptosis Signaling Pathway

Apoptosis, also known as programmed cell death, is a crucial process in maintaining healthy tissue function and development. It is a well-orchestrated series of events that leads to the controlled elimination of damaged or unnecessary cells. The apoptosis signaling pathway can be initiated from within the cell (intrinsic pathway) or from external signals (extrinsic pathway).
The intrinsic pathway is often triggered by internal stress, such as DNA damage or oxidative stress. Key players in this pathway include the mitochondria and various proteins, like cytochrome c and caspases, which execute the cell death program.
The extrinsic pathway, on the other hand, begins when external signals bind to death receptors on the cell surface. This pathway involves the binding of ligands, such as Fas ligand (FasL) or tumor necrosis factor (TNF), to their respective receptors. Activation of these receptors leads to the formation of a death-inducing signaling complex (DISC), which ultimately activates caspases to carry out apoptosis.
Failure in any part of these pathways, such as defective signaling or receptor issues, can prevent apoptosis, potentially allowing cancer cells to survive uncontrollably.

Mutation

Mutations are changes in the DNA sequence of a cell’s genome and can have profound effects on cell functions. In the context of cancer cells, mutations often lead to uncontrolled growth and a failure to undergo apoptosis. There are various types of mutations, including point mutations, deletions, insertions, and complex rearrangements.
Mutations can occur in genes that regulate apoptosis, such as those coding for components of the apoptosis signaling pathways or apoptosis receptors. For instance, a mutation in the gene coding for a receptor in the extrinsic pathway could prevent the receptor from binding to its ligand, thereby halting the apoptosis signal.
When a cell fails to initiate apoptosis due to a mutation, it may become resistant to death even when exposed to apoptosis-inducing factors. This resistance is a common feature in cancer cells, allowing them to survive and proliferate beyond normal constraints. Understanding the specific mutations that disrupt apoptosis is critical for developing effective cancer therapies.

Receptor Expression

Receptors are proteins on the cell surface or within cells that bind to specific molecules, triggering a response from the cell. In the apoptosis signaling pathway, receptors play a pivotal role in recognizing apoptosis-inducing signals.
For example, death receptors like Fas or TNF receptor must bind to their ligands to start the apoptosis process. If the cell loses expression of these receptors, it cannot detect the apoptosis signal and therefore will not initiate apoptosis.
Loss of receptor expression can occur through various mechanisms, including genetic mutations, epigenetic changes, or down-regulation of receptor production. Without proper receptor expression, cancer cells may avoid programmed cell death, contributing to their survival and uncontrolled growth. Understanding how receptor expression is regulated can provide insights into new therapeutic strategies to induce apoptosis in cancer cells.

Growth Factor Pathway

Growth factors are proteins that bind to receptors on the cell surface, stimulating cellular growth, proliferation, and survival. These pathways can play a significant role in inhibiting apoptosis and promoting cancer cell survival.
One common growth factor pathway involved in cancer is the PI3K/Akt pathway. When growth factors bind to their receptors, they activate PI3K, which, in turn, activates Akt. Active Akt promotes cell survival by inhibiting apoptosis and supporting growth and proliferation.
In many cancers, this pathway is overactive due to mutations or overexpression of growth factors or their receptors. When this pathway is upregulated, even in the presence of apoptosis inducers, cancer cells might not undergo apoptosis because the survival signals outweigh the death signals.
Targeting growth factor pathways in cancer treatment aims to restore the balance between survival and apoptosis, making cancer cells more susceptible to programmed cell death.